Literature DB >> 28975157

Cervical artery dissection and iliac artery aneurysm in an SMAD-4 mutation carrier.

Emmanuel Wiener1, Peter Martin1, Sarju Mehta1, Hugh Stephen Markus1.   

Abstract

Entities:  

Year:  2017        PMID: 28975157      PMCID: PMC5619912          DOI: 10.1212/NXG.0000000000000191

Source DB:  PubMed          Journal:  Neurol Genet        ISSN: 2376-7839


× No keyword cloud information.

Case report.

Cervical artery dissection is an important cause of stroke, especially in younger individuals. Most cases appear to be sporadic, but rare monogenic conditions can cause dissection, such as vascular Ehlers-Danlos syndrome.[1] The wider use of sequencing techniques in clinical diagnosis of genetic disorders has made it more realistic to test for multiple genes in potential monogenic stroke conditions. Here, we report the case of a cervical artery dissection in a SMAD-4 mutation carrier. This patient is a 48-year-old man with a history of hypertension, aortic root dilation that led to surgical replacement at age 41, and a subsequent right common iliac artery aneurysm. He had experienced several episodes of mild epistaxis, but none had needed specific treatment. There was no personal history of gastrointestinal symptoms or bleeding. His family history was suggestive of juvenile polyposis syndrome (JPS). Several colon polyps were diagnosed in his mother; his brother had experienced several episodes of serious digestive bleeding related to multiple colon polyps. The patient has 2 sons and 2 daughters. At age 4, his eldest daughter has had an episode of rectal bleeding that led to the diagnosis of colon polyps; his youngest son has experienced an episode of epistaxis. His youngest daughter and eldest son are doing well. Physical examination showed slightly translucent chest skin and a possible small telangiectasia in his right cheek. There were no other skin abnormalities; joint examination was unremarkable; heart and neck auscultation was normal. Because of the aortic and iliac arteriopathy, cerebral CT angiogram was performed to screen for cerebral artery abnormalities. The angiogram revealed 3 findings (figure): firstly, abnormal increased tortuosity of both internal carotids; secondly, mild arterial diameter irregularities; and thirdly, a short but distinct dissection flap in the V2 segment of the right vertebral artery, at the level of C5. The patient had no history of stroke, neck pain, or trauma; therefore, it was not possible to date the dissection. No intracranial abnormality, aneurysm, or arteriovenous malformation was found.
Figure

Cervical artery abnormalities

(A–C) Abnormal tortuosity of carotid arteries. (D) Mild diameter irregularities. (E) Right vertebral artery dissection flap.

Cervical artery abnormalities

(A–C) Abnormal tortuosity of carotid arteries. (D) Mild diameter irregularities. (E) Right vertebral artery dissection flap. Owing to his multifocal arteriopathy, genetic screening was performed using an arteriopathy gene panel. A heterozygous, loss-of-function, nonsense mutation was found in exon 10 of the SMAD-4 gene (c.1336C>T; protein change p.Gln446Ter). This Class 4, likely pathogenic mutation, is predicted to create a premature termination codon, resulting in a truncated protein. This mutation has not been identified within in-house databases or in individuals from the Exome Aggregation Consortium project, although a similar c.1333C>T mutation (p.Arg445Ter) has been reported in a patient with JPS, aortic root dilation, and mitral valvulopathy.[2] Segregation studies have been advised to confirm pathogenicity via the Clinical Genetics department.

Discussion.

This case illustrates that cervical artery abnormal tortuosity and dissection can occur as part of a systemic arteriopathy due to SMAD-4 mutation. SMAD-4 protein is involved in the transforming growth factor beta signaling pathway. The chromosomal location of the SMAD-4 gene is 18q21.1. Several SMAD-4 loss-of-function mutations have been described among patients with JPS and hereditary hemorrhagic telangiectasia (HHT), 2 genetically heterogeneous autosomal dominant disorders. JPS, occurring in approximately 1/100,000 individuals, is characterized by early-onset colorectal and gastric polyp formation, with a subsequent risk of digestive bleeding, anemia, and malignancy. SMAD-4 and BMPR1A mutations are the most frequently found. The largest JPS series to date has found SMAD-4 mutations in 21% of cases.[3] HHT, affecting approximately 1/5,000–10,000 individuals, is a multifocal vascular dysplasia, with skin and mucosal telangiectases and visceral arteriovenous malformations (lung, brain, and liver). Recurrent epistaxis is the most frequent manifestation. The most frequently involved genes are ACVRL1, ENG, and SMAD-4. Patient series suggest that SMAD-4 mutations account for 2% of cases.[4] JPS and HHT can be associated in the same individual, usually in case of a SMAD-4 mutation. Cardiovascular abnormalities have been described in SMAD-4 mutation carriers. Thoracic aortopathy (aortic root dilation) has been reported in 9%–37% of patients[5-7]; heart valve regurgitation in 6%,[5] and intracranial aneurysm in 3%.[5] However, involvement of the cervical and iliac arteries does not seem to be a typical feature of this condition. This report extends the number of monogenic causes of cervical artery dissection and highlights that SMAD-4 mutations can cause systemic multifocal arteriopathy, involving not only the aortic root but also the cervical and iliac arteries. Vascular imaging of the arterial tree is advised in at-risk individuals.
  7 in total

Review 1.  The genetics of cervical artery dissection: a systematic review.

Authors:  Stéphanie Debette; Hugh S Markus
Journal:  Stroke       Date:  2009-04-23       Impact factor: 7.914

2.  Prevalence of thoracic aortopathy in patients with juvenile Polyposis Syndrome-Hereditary Hemorrhagic Telangiectasia due to SMAD4.

Authors:  Brandie Heald; Christina Rigelsky; Rocio Moran; Lisa LaGuardia; Margaret O'Malley; Carol A Burke; Kenneth Zahka
Journal:  Am J Med Genet A       Date:  2015-04-30       Impact factor: 2.802

3.  Hereditary haemorrhagic telangiectasia: mutation detection, test sensitivity and novel mutations.

Authors:  N L Prigoda; S Savas; S A Abdalla; B Piovesan; D Rushlow; K Vandezande; E Zhang; H Ozcelik; B L Gallie; M Letarte
Journal:  J Med Genet       Date:  2006-05-11       Impact factor: 6.318

4.  SMAD4 mutation segregating in a family with juvenile polyposis, aortopathy, and mitral valve dysfunction.

Authors:  Sara Andrabi; Mir Reza Bekheirnia; Patricia Robbins-Furman; Richard Alan Lewis; Thomas W Prior; Lorraine Potocki
Journal:  Am J Med Genet A       Date:  2011-04-04       Impact factor: 2.802

5.  JP-HHT phenotype in Danish patients with SMAD4 mutations.

Authors:  A M Jelsig; P M Tørring; A D Kjeldsen; N Qvist; A Bojesen; U B Jensen; M K Andersen; A M Gerdes; K Brusgaard; L B Ousager
Journal:  Clin Genet       Date:  2015-12-21       Impact factor: 4.438

6.  The rate of germline mutations and large deletions of SMAD4 and BMPR1A in juvenile polyposis.

Authors:  D Calva-Cerqueira; S Chinnathambi; B Pechman; J Bair; J Larsen-Haidle; J R Howe
Journal:  Clin Genet       Date:  2008-09-24       Impact factor: 4.438

7.  Appreciating the broad clinical features of SMAD4 mutation carriers: a multicenter chart review.

Authors:  Karen E Wain; Marissa S Ellingson; Jamie McDonald; Amanda Gammon; Maegan Roberts; Pavel Pichurin; Ingrid Winship; Douglas L Riegert-Johnson; Jeffrey N Weitzel; Noralane M Lindor
Journal:  Genet Med       Date:  2014-02-13       Impact factor: 8.822

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.